LUSPATERCEPT-AAMT for Myelofibrosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where LUSPATERCEPT-AAMT was used for Myelofibrosis.
Most Reported Side Effects for LUSPATERCEPT-AAMT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 162 | 9.6% | 160 | 4 |
| Haemoglobin decreased | 98 | 5.8% | 3 | 15 |
| Fatigue | 86 | 5.1% | 0 | 12 |
| Off label use | 85 | 5.1% | 5 | 20 |
| Weight decreased | 76 | 4.5% | 0 | 9 |
| Dizziness | 64 | 3.8% | 0 | 12 |
| Product storage error | 64 | 3.8% | 0 | 0 |
| Drug ineffective | 58 | 3.5% | 0 | 6 |
| Dyspnoea | 52 | 3.1% | 1 | 10 |
| Fall | 51 | 3.0% | 4 | 25 |
| Weight increased | 44 | 2.6% | 0 | 3 |
| Myelodysplastic syndrome | 39 | 2.3% | 8 | 10 |
| Headache | 37 | 2.2% | 0 | 10 |
| Hospitalisation | 37 | 2.2% | 1 | 36 |
| Adverse event | 36 | 2.1% | 1 | 2 |
Other Indications for LUSPATERCEPT-AAMT
Product used for unknown indication (695)
Myelodysplastic syndrome (609)
Anaemia of malignant disease (120)
Thalassaemia beta (113)
Anaemia (66)
Thalassaemia (21)
Myelodysplastic syndrome with ringed sideroblasts (12)
Myelodysplastic syndrome with single lineage dysplasia (12)
Off label use (7)
Refractory anaemia with ringed sideroblasts (7)
Other Drugs Used for Myelofibrosis
RUXOLITINIB (21,650)
PACRITINIB (1,586)
JAKAFI (1,314)
FEDRATINIB (682)
MOMELOTINIB (526)
LENALIDOMIDE (496)
THALIDOMIDE (349)
DEFERASIROX (150)
HYDROXYUREA (129)
JAKAVI (98)